UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 69

Sortiert nach

Ets regulation of the erbB2 promoter

Oncogene, 2000-12, Vol.19 (55), p.6490-6502

2000

Link zum Volltext

Verfügbarkeit prüfen

Involvement of the Tpl-2/cot oncogene in MMTV tumorigenesis

Oncogene, 1996-11, Vol.13 (9), p.2015-2020

1996

Link zum Volltext

Verfügbarkeit prüfen

Exenatide versus insulin glargine: a cost-effectiveness evaluation in patients with Type 2 diabetes in Switzerland

International journal of clinical pharmacology and therapeutics, 2009-08, Vol.47 (8), p.501

2009

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness of pioglitazone in patients with type 2 diabetes and a history of macrovascular disease in a Swiss setting

Swiss medical weekly, 2009-03, Vol.139 (11-12), p.173

2009

Link zum Volltext

Verfügbarkeit prüfen

conformational immunogen on VP-2 of infectious bursal disease virus that induces virus-neutralizing antibodies that passively protect chickens

Journal of general virology, 1989-06, Vol.70 (6), p.1473-1481

1989

Link zum Volltext

Verfügbarkeit prüfen

Immunological and molecular comparison of fowl adenovirus serotypes 4 and 10

Archives of virology, 1995, Vol.140 (3), p.491-501

1995

Link zum Volltext

Verfügbarkeit prüfen

Therapy conversion to insulin detemir among patients with type 2 diabetes treated with oral agents: a modeling study of cost-effectiveness in the United States

Advances in therapy, 2007-03, Vol.24 (2), p.273-290

2007

Link zum Volltext

Verfügbarkeit prüfen

Molecular characterization of highly virulent fowl adenoviruses associated with outbreaks of inclusion body hepatitis

Avian pathology, 1991-12, Vol.20 (4), p.597-606

1991

Link zum Volltext

Verfügbarkeit prüfen

ESX : a structurally unique Ets overexpressed early during human breast tumorigenesis

Oncogene, 1997-04, Vol.14 (13), p.1617-1622

1997

Link zum Volltext

Verfügbarkeit prüfen

Virus-neutralizing and passively protective monoclonal antibodies to infectious bursal disease virus of chickens

Avian diseases, 1991-04, Vol.35 (2), p.365

1991

Link zum Volltext

Verfügbarkeit prüfen

Immunopathogenesis and physical maps of fowl adenovirus serotype 9

Research in veterinary science, 1996-09, Vol.61 (2), p.174-175

1996

Link zum Volltext

Verfügbarkeit prüfen

ESX: a structurally unique Ets overexpressed early during human breast tumorigenesis

Oncogene, 1997-04, Vol.14 (13), p.1617-1622

1997

Link zum Volltext

Verfügbarkeit prüfen

Serological relationships within the group E fowl adenoviruses

Intervirology, 1993, Vol.36 (2), p.84

1993

Link zum Volltext

Verfügbarkeit prüfen

Replication cycle and associated biosynthetic reactions for a non-oncogenic avian adenovirus

Virus research, 1993-08, Vol.29 (2), p.203-209

1993

Link zum Volltext

Verfügbarkeit prüfen

DNA sequence analysis of the inverted terminal repeats of a non-oncogenic avian adenovirus

Nucleic acids research, 1989-05, Vol.17 (10), p.3995-3995

1989

Link zum Volltext

Verfügbarkeit prüfen

Expression in Escherichia coli of cDNA fragments encoding the gene for the host-protective antigen of infectious bursal disease virus

Virology (New York, N.Y.), 1986-03, Vol.149 (2), p.190-198

1986

Link zum Volltext

Verfügbarkeit prüfen

PDB47 LONG-TERM ECONOMIC OUTCOMES ASSOCIATED WITH INSULIN ASPART VERSUS HUMAN BOLUS INSULIN IN TYPE 2 DIABETES PATIENTS IN THE SWEDISH SETTING

Value in health, 2007, Vol.10 (6), p.A268-A269

2007

Link zum Volltext

Verfügbarkeit prüfen

PDB22 EVALUATING THE LONG-TERM COST-EFFECTIVENESS OF INSULIN ASPART (NOVORAPID®) VERSUS HUMAN SOLUBLE INSULIN IN PATIENTS WITHTYPE 2 DIABETES IN SPAIN AND ITALY

Value in health, 2007, Vol.10 (6), p.A260-A260

2007

Link zum Volltext

Verfügbarkeit prüfen

PDB37 MEALTIME INSULIN ASPART REDUCES THE LONG-TERM COST OF COMPLICATIONS COMPARED TO HUMAN INSULIN AS PART OF BASAL-BOLUS THERAPY IN POLISH TYPE 2 DIABETES PATIENTS

Value in health, 2007, Vol.10 (6), p.A265-A265

2007

Link zum Volltext

Verfügbarkeit prüfen

PDB63 ESTIMATING THE LONG-TERM CLINICAL OUTCOMES ASSOCIATED WITH SWITCHING TO INSULIN ASPART (NOVORAPID®) FROM HUMAN SOLUBLE INSULIN IN TYPE 2 DIABETES PATIENTS IN THE POLISH SETTING

Value in health, 2007, Vol.10 (6), p.A274-A274

2007

Link zum Volltext

Verfügbarkeit prüfen

ED2 LONG-TERM COST-UTILITY ANALYSIS OF INSULIN ASPART (NOVORAPID®) VERSUS HUMAN SOLUBLE INSULIN INTYPE 2 DIABETES PATIENTS IN THE GERMAN SETTING

Value in health, 2007, Vol.10 (6), p.A222-A223

2007

Link zum Volltext

Verfügbarkeit prüfen

DNA sequence analysis of the inverted terminal repeats of a non-oncogenic adenovirus

Nucleic acids research, 1989-01, Vol.17 (10), p.3995-3995

1989

Link zum Volltext

Verfügbarkeit prüfen

MD3 VALIDATING A DISEASE MODEL ACCORDING TO CRITERIA OF EVIDENCE BASED MEDICINE

Value in health, 2002-11, Vol.5 (6), p.449-449

2002

Link zum Volltext

Verfügbarkeit prüfen

Molecular characterization of highly virulent fowl adenoviruses associated with outbreaks of inclusion body

Avian pathology, 1991-01, Vol.20 (4), p.597-606

1991

Link zum Volltext

Verfügbarkeit prüfen

Expression in Escherichia coli of DNA fragments encoding the gene for the host-protective antigen of infectious bursal disease virus

Virology (New York, N.Y.), 1986, Vol.149 (2), p.190-198

1986

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 69

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(61)
Mit Volltextzugriff
(56)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(30)
Life Sciences & Biomedicine
(20)
Humans
(13)
Biological And Medical Sciences
(11)
Female
(9)
Fundamental And Applied Biological Sciences. Psychology
(8)
Physical Sciences
(8)
Animals
(7)
Chickens
(6)
Microbiology
(6)
Physics
(6)
Virology
(6)
Internal Medicine
(5)
Male
(5)
Antibodies, Viral - Biosynthesis
(4)
Dna
(4)
Technology
(4)
Adenovirus
(3)
Aviadenovirus
(3)
Aviadenovirus - Genetics
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Ets regulation of the erbB2 promoter

Involvement of the Tpl-2/cot oncogene in MMTV tumorigenesis

Exenatide versus insulin glargine: a cost-effectiveness evaluation in patients with Type 2 diabetes in Switzerland

Cost-effectiveness of pioglitazone in patients with type 2 diabetes and a history of macrovascular disease in a Swiss setting

conformational immunogen on VP-2 of infectious bursal disease virus that induces virus-neutralizing antibodies that passively protect chickens

Immunological and molecular comparison of fowl adenovirus serotypes 4 and 10

Therapy conversion to insulin detemir among patients with type 2 diabetes treated with oral agents: a modeling study of cost-effectiveness in the United States

Molecular characterization of highly virulent fowl adenoviruses associated with outbreaks of inclusion body hepatitis

ESX : a structurally unique Ets overexpressed early during human breast tumorigenesis

Virus-neutralizing and passively protective monoclonal antibodies to infectious bursal disease virus of chickens

Immunopathogenesis and physical maps of fowl adenovirus serotype 9

ESX: a structurally unique Ets overexpressed early during human breast tumorigenesis

Serological relationships within the group E fowl adenoviruses

Replication cycle and associated biosynthetic reactions for a non-oncogenic avian adenovirus

DNA sequence analysis of the inverted terminal repeats of a non-oncogenic avian adenovirus

Expression in Escherichia coli of cDNA fragments encoding the gene for the host-protective antigen of infectious bursal disease virus

PDB47 LONG-TERM ECONOMIC OUTCOMES ASSOCIATED WITH INSULIN ASPART VERSUS HUMAN BOLUS INSULIN IN TYPE 2 DIABETES PATIENTS IN THE SWEDISH SETTING

PDB22 EVALUATING THE LONG-TERM COST-EFFECTIVENESS OF INSULIN ASPART (NOVORAPID®) VERSUS HUMAN SOLUBLE INSULIN IN PATIENTS WITHTYPE 2 DIABETES IN SPAIN AND ITALY

PDB37 MEALTIME INSULIN ASPART REDUCES THE LONG-TERM COST OF COMPLICATIONS COMPARED TO HUMAN INSULIN AS PART OF BASAL-BOLUS THERAPY IN POLISH TYPE 2 DIABETES PATIENTS

PDB63 ESTIMATING THE LONG-TERM CLINICAL OUTCOMES ASSOCIATED WITH SWITCHING TO INSULIN ASPART (NOVORAPID®) FROM HUMAN SOLUBLE INSULIN IN TYPE 2 DIABETES PATIENTS IN THE POLISH SETTING

ED2 LONG-TERM COST-UTILITY ANALYSIS OF INSULIN ASPART (NOVORAPID®) VERSUS HUMAN SOLUBLE INSULIN INTYPE 2 DIABETES PATIENTS IN THE GERMAN SETTING

DNA sequence analysis of the inverted terminal repeats of a non-oncogenic adenovirus

MD3 VALIDATING A DISEASE MODEL ACCORDING TO CRITERIA OF EVIDENCE BASED MEDICINE

Molecular characterization of highly virulent fowl adenoviruses associated with outbreaks of inclusion body

Expression in Escherichia coli of DNA fragments encoding the gene for the host-protective antigen of infectious bursal disease virus

Suchergebnisse filtern